Discover the top abstracts of note for the 2023 ASH annual meeting.
Read MoreFirst of Its Kind: Oncology Pharmacovigilance Clinic
Cleveland Clinic is the first to create a multidisciplinary clinic to triage and care for patients with immune-related adverse events.
Study Demonstrates Fewer Toxicities and Faster Engraftment with Reduced-Dose Methotrexate for Preventing Graft-Versus-Host Disease
Researchers strive to find optimal approach for reducing toxicities resulting from graft-versus-host-disease prophylaxis treatment.
A Germline Biomarker Offers Insight Into Treatment Selection for Men With Prostate Cancer
Research study aims to identify biomarkers for predicting response to prostate cancer treatment.
Symptom Resolution Achieved in More than 90 Percent of Patients Under Palliative Care
Palliative medicine physician David Harris, MD, discusses best practices and recent advances in managing gastrointestinal symptoms in patients with cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Low-Dose Radiation Therapy Reemerging for Osteoarthritis
Use of low-dose radiation a non-invasive treatment for certain types of osteoarthritis
Studying Ultra-Hypofractionated Radiotherapy for Soft Tissue Sarcoma
Research team found ultra-hypofractionated radiotherapy improved on the current standard of care for treating soft tissue sarcoma.
Paget’s Disease of the Breast a Little Understood Form of DCIS
Breast Surgery Specialist Stephanie Valente, DO, discusses the diagnosis and treatment of Paget’s disease, a rare form of ductal carcinoma in situ that may look like eczema or psoriasis of the nipple and areola.
Cleveland Clinic Cancer Center and National Organization for Rare Disorders Partner to Accelerate Diagnosis and Treatment of Rare Cancers
Cleveland Clinic’s Director of Rare Cancers and Blood Diseases explains how having a formalized system in place for treating rare cancers can shorten the diagnostic odyssey and help improve patient outcomes and quality of life.
p53-Independent Non-Cytotoxic Therapy May be a Viable Option for Chemotherapy-Resistant Small Cell Lung Cancer
Researchers delve into the origins of drug resistance in small cell lung cancer.
The Role of Immune Escape in Post-Transplant Leukemia Relapse
New study yields clues to the cause of relapse after bone marrow transplant in patients with certain types of leukemia.